Celentyx
Birmingham
About Celentyx
Celentyx Ltd is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis and neuroinflammation. Drawing on the World-leading expertise of Celentyx personnel, along with our close association with the MRC Centre for Immune Regulation and the Centre for Translational Inflammation Research enables the human immune system in health and disease to be investigated at the highest levels of resolution.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Dec 2007)
- Website: celentyx.com
Industries & Categories
Association, Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/celentyx-2621155 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.